ライフサイエンスコーパス: standard deviation

1 ective radiation dose was 0.56 mSv +/- 0.25 (standard deviation).

2 122 women, mean age was 58.6 years +/- 10.1 (standard deviation).

3 alues of the CA parameters and increased the standard deviation.

4 Data are presented as mean +/- standard deviation.

5 logy had less index variability with smaller standard deviations.

6 scaling law as a benchmark for the observed standard deviations.

7 76 healthy women (mean age, 54 years +/- 10 [standard deviation]).

8 55 086 women (mean age, 57.3 years +/- 11.6 [standard deviation]).

9 ith HCM (733 men; mean age, 49 years +/- 17 [standard deviation]).

10 male, 75 female; mean age, 57 years +/- 17 [standard deviation]).

11 034 patients (mean age, 60.6 years +/- 14.2 [standard deviation]).

12 tween native baseline measurements was high (standard deviation = 0.02 mm in normal and in dry eyes).

13 of small vessel stroke [odds ratio (OR) per standard deviation = 0.85, 95% confidence interval (CI)

14 lly/ethnically diverse adults (mean age, 62 (standard deviation, 10) years) free of known cardiovascu

15 from 19 patients (mean age, 11 years +/- 5 [standard deviation]; 10 female patients) were evaluated.

16 Eleven astronauts (mean age, 45 years +/- 5 [standard deviation]; 10 men) showed increased mean volum

17 ecutive patients (mean age, 66 years +/- 13 [standard deviation]; 10 men) suspected of having lung ca

18 hest radiographs; mean age, 62 years +/- 16 [standard deviation]; 1059 men) with COVID-19 pneumonia a

19 al, 118 patients (mean age, 40 years +/- 10 [standard deviation]; 108 women) were evaluated, includin

20 eted by 2,961 patients (mean age 65.1 years, standard deviation 11.7 years), most of whom were women

21 ow-up range 11 to 42 months; mean 24 months, standard deviation 11.8 months), retinal reattachment wi

22 eived sunitinib (mean age, 59 years +/- 7.0 [standard deviation]; 11 men); 11 participants received p

23 rom 212 patients (mean age, 55 years +/- 17 [standard deviation]; 113 women) with 35 neurologic disea

24 ed normative data [14 female, mean age 58.0 (standard deviation 12.9) years].

25 Results Seventeen participants (mean age +/- standard deviation, 13 years +/- 5; nine male) were in t

26 BCVA from baseline was -5.9 letters correct (standard deviation, 13.0 letters correct) in the interve

27 ty-five patients (mean age, 54 years +/- 18 [standard deviation]; 13 men) were evaluated.

28 These patients were younger (mean age 48.3 [standard deviation 14.2]-vs.-55.0 [13.3],p = 0.047) and

29 for both study groups at month 36 (mean +/- standard deviation 14.5+/-5.1 and 14.8+/-5.3, respective

30 ticipants with ET (mean age, 72 years +/- 6 [standard deviation]; 14 men), 17 participants with PD (m

31 hotoreceptor density was 14 988 cells/mm(2) (standard deviation, 1403.15 cells/mm(2)).

32 7) in controls with itch compared with 82.9 (standard deviation = 15.6) in controls without itch (P <

33 patients without itch (P < 0.001) and 74.9 (standard deviation = 15.7) in controls with itch compare

34 patients (31 men; mean age, 58 years +/- 12 [standard deviation]; 15 patients per center; three cente

35 udy evaluated 265 patients (53 years +/- 14 [standard deviation]; 164 men).

36 ) in patients with itch, compared with 74.7 (standard deviation = 18.0) in patients without itch (P <

37 ult participants (mean age, 49 years +/- 17 [standard deviation]; 18 men and two women) were included

38 Results Forty-five patients (mean age +/- standard deviation, 19 years +/- 5; 27 female) and 57 hi

39 of 307 patients (mean age, 68 years +/- 11 [standard deviation]; 192 men) were evaluated.

40 During an average follow-up of 11.5 (standard deviation = 2.3) years, 1,757 deaths were recor

41 sporadic, biopsy-proven RCC (median size +/- standard deviation, 2.8 cm +/- 1.4) were included.

42 by the EQ-5D visual analogue scale was 65.9 (standard deviation = 20.1) in patients with itch, compar

43 ts were included (mean age, 55 years +/- 11 [standard deviation]; 208 men).

44 4166 participants (mean age, 60 years +/- 9 [standard deviation]; 2091 [50%] men) were evaluated.

45 ulmonary nodules (mean size, 8.6 mm +/- 3.4 [standard deviation]; 21 part-solid nodules) in 42 patien

46 talized patients (mean age, 69 years +/- 12 [standard deviation]; 237 men) of whom 168 (47%) develope

47 six participants (mean age, 47 years +/- 19 [standard deviation]; 24 men [52%]) were enrolled, and 75

48 d 269 patients with PEX (19.7 years +/- 7.8 [standard deviation]; 245 men) and 35 healthy volunteers

49 orty-six patients (mean age, 46 years +/- 7 [standard deviation]; 25 women) with 100 ccRCCs were eval

50 rom 419 patients (mean age, 52 years +/- 18 [standard deviation]; 250 women) with histologic diagnosi

51 ic adult patients (mean age, 64 years +/- 9 [standard deviation]; 2567 women) underwent mt-sDNA scree

52 s, 4824 patients (mean age, 64 years +/- 19 [standard deviation], 2669 male) were included.

53 verage imaging session time was 4.6 minutes (standard deviation, 3.0 minutes) for Optos P200DTx and 5

54 minutes) for Optos P200DTx and 5.2 minutes (standard deviation, 3.0 minutes) for Zeiss Clarus 500 (P

55 aqueous solution was satisfactory (relative standard deviation, 3.6-18.3%).

56 cipants with CKD (mean age, 59 years +/- 13 [standard deviation]; 30 women) were evaluated.

57 of 5853 patients (mean age, 58 years +/- 19 [standard deviation]; 3101 women) were evaluated across d

58 al of 36 patients (mean age, 58 years +/- 5 [standard deviation]; 32 men) with 53 lesions was include

59 ecutive patients (mean age, 59 years +/- 11 [standard deviation]; 35 women) underwent preventive FICS

60 al of 311 neonates (mean gestational age +/- standard deviation, 39.3 weeks +/- 1.5), including 57 wi

61 629 patients (mean age, 52.2 years +/- 20.4 [standard deviation]; 394 men).

62 he liberal-strategy group (mean, 2.73 units [standard deviation, 4.81 units] v 5.02 units [standard d

63 Results Twenty-three patients (mean age +/- standard deviation, 43 years +/- 18; 13 women) were eval

64 of 52 participants with NMOSDs (mean age +/- standard deviation, 44 years +/- 15; 45 women) and 28 ag

65 oms in 172 patients (66% women; mean age +/- standard deviation, 45 +/- 12 years; 133 with gastropare

66 79 ovarian lesions in 58 women (mean age +/- standard deviation, 48 years +/- 14) were evaluated.

67 esting for up to 24 years (mean = 9.9 years, standard deviation = 5.0), died, and underwent a neuropa

68 Over an average follow-up of 20.4 years (standard deviation, 5.9), 445 participants developed fra

69 sults Fifty-three participants (mean age +/- standard deviation, 51 years +/- 15.2; 32 men) were eval

70 t of 86 patients (mean age, 49 years +/- 16 [standard deviation]; 53 women).

71 althy adults (mean age, 42.4 years +/- 10.5 [standard deviation]; 538 men).

72 patients (average age, 60.2 years +/- 19.9 [standard deviation], 55.6% men) between 2010 and 2018 co

73 0 healthy control participants (mean age +/- standard deviation, 56 years +/- 11; 11 women), 29 parti

74 ticipants with AD (mean age, 73 years +/- 9 [standard deviation]; 58 women) and 100 age-matched HC pa

75 ts A total of 125 participants (mean age +/- standard deviation, 59 years +/- 12; 80 men) with comple

76 of 7143 COPDGene participants (mean age +/- standard deviation, 59.8 years +/- 8.9; 3734 men and 340

77 128 children (mean age, 33.9 months +/- 1.8 [standard deviation]; 59 girls, 69 boys) were evaluated.

78 Ninety patients (mean age, 44 years +/- 15 [standard deviation]; 59 women) were evaluated.

79 tandard deviation, 4.81 units] v 5.02 units [standard deviation, 6.13 units]; P = .0004).

80 Mean age was 71 years (standard deviation, 6.6); 56.5% were female.

81 Mean age was 71.0 years (standard deviation, 6.7 years), and 56.5% of patients we

82 of 105 patients (mean age, 62 years +/- 16 [standard deviation]; 61 men) and 262 patients (mean age,

83 udy participants (mean age, 64 years +/- 11 [standard deviation]; 61 men) were evaluated.

84 T-PCR) was performed (mean, 62 years +/- 16 [standard deviation]; 61 men, 53 with positive RT-PCR res

85 th Fabry disease (mean age, 46 years +/- 14 [standard deviation]; 63% female) who underwent TTE and c

86 database of 962 cases (mean patient age +/- standard deviation, 65 years +/- 17; 255 male patients;

87 A total of 317 consecutive men (mean age +/- standard deviation, 65 years +/- 8) were treated.

88 in 105 skiers (mean age, 14.8 years +/- 0.6 [standard deviation]; 66 boys) and in 105 control partici

89 udy participants (mean age, 56 years +/- 15 [standard deviation]; 66 women) were evaluated.

90 2992 patients; mean age, 76.8 years +/- 6.0 [standard deviation]; 66% female).

91 ged-in-care HCV CVL was 4 351 079 copies/mL (standard deviation = 7 149 888); local HCV CVLs varied b

92 mean age of the participants was 60.1 years (standard deviation, 7.4 years).

93 icipants with DPN (mean age, 65 years +/- 9 [standard deviation]; 70% men; mean BMI, 34 kg/m(2) +/- 5

94 Mean age was 79.4 (standard deviation = 8.4) years; 53.1% were women.

95 n interquartile range of 3.3 to 13.1 months (standard deviation, 8.7 months).

96 The mean age was 74.4 years (standard deviation:8.7 years); 63.9% were women, 19.4% h

97 d three patients (mean age, 72 years +/- 11 [standard deviation]; 81 men) were evaluated.

98 79 beneficiaries (mean age, 63 years +/- 15 [standard deviation]; 820 men) in 2009.

99 e intervention eye and -3.7 letters correct (standard deviation, 9.0 letters correct) in the fellow e

100 755 device leads (mean age, 67 years +/- 15 [standard deviation]; 930 men [64%]).

101 779 patients (average age, 53 years +/- 19 [standard deviation]; 99 106 men) who underwent cardiac M

102 this cohort had CISS scores greater than one standard deviation above the mean found by Borsting et a

103 riability in sleep onset, assessed using the standard deviation across all nights recorded, was assoc

104 underwent MRI an average of 5 days +/- 1.9 (standard deviation) after reperfusion.

105 The mean +/- standard deviation age at the index date was 69.0 +/- 1.

106 of participants were male, their average +/- standard deviation age was 65+/-9 years.

107 iments and 10 healthy participants (mean +/- standard deviation age, 29 years +/- 13).

108 atients (40 female, 19 male) with a mean (+/-standard deviation) age at baseline of 76.60+/-6.65 year

109 The mean (standard deviation) age was 70.7 (8.0) years and 55.6% w

110 riteria, with a mean age of 61 years +/- 12 (standard deviation) (age range, 8-78 years).

111 udy population comprised 491 subjects [mean (standard deviation): age 44.6 yrs (13.0), body mass inde

112 Thirty women (mean age, 51.1 years +/- 10.1 [standard deviation]; age range, 27-70 years) with 37 les

113 ive participants (mean age, 60 years +/- 13 [standard deviation]; all women) were evaluated.

114 der the curve [AUC] = 0.924) and combined D* standard deviation and F (p) kurtosis (AUC = 0.916) for

115 sing data-dependent statistics, specifically standard deviation and mean.

116 d results, and pooled clinical specimens had standard deviations and coefficients of variation rangin

117 hm of the minimum angle of resolution), with standard deviations and ranges where available.

118 here are errors with the presentation of the standard deviations and statistical significance shown i

119 tebrae identification rate of 88.5% +/- 0.2 (standard deviation) and localization distances of less t

120 tic pairings for 2015 (3 of 23: IOP, pattern standard deviation, and 7-o'clock RNFL thickness) and 20

121 breast cancer (median age, 62 years +/- 17 [standard deviation]) and 1225 matched control patients (

122 althy volunteers (mean age, 49 years +/- 13 [standard deviation]) and eight patients (mean age, 54 ye

123 (31 men, 31 women; mean age, 67 years +/-17 [standard deviation]), and group 2 comprised 57 patients

124 The values obtained for relative standard deviation, as well as for precision, in terms o

125 24; 14 males; mean age, 14.5 years +/- 7.8 [standard deviation] at first examination).

126 dren with low and high initial SSB intake (1 standard deviation below and above the mean) and 1.17 be

127 Relative standard deviations below 1.5% were observed for interla

128 ation yielded very similar results (relative standard deviation between 2-PIC and external calibratio

129 ltiple Poisson regression indicated that a 1-standard-deviation change in predisaster social cohesion

130 overall cancer risk (odds ratio [OR] per one standard deviation decrease in low-density lipoprotein [

131 Moreover, a comparison of relative standard deviation distribution between modes shows cons

132 s reproducible and correct results: relative standard deviation does not exceed 8.4% and recovery of

133 The mean +/- standard deviation follow-up period was 14.6+/-3.1 years

134 NO(3) and NH(4)NO(3) particles, with maximum standard deviations for delta(15)N and delta(18)O of +/-

135 ved mean Dice coefficients of 0.96 +/- 0.01 (standard deviation) for LV blood cavity, 0.89 +/- 0.03 f

136 osite risk score was 3.09 +/- 6.40 (mean +/- standard deviation) for patients with capsule complicati

137 efficient in the test set was 0.80 +/- 0.04 (standard deviation) for the arteries and 0.88 +/- 0.03 f

138 mean PM(2.5) concentration and corresponding standard deviation from a published epidemiologic study

139 able recovery (higher than 94%) and relative standard deviation from spiked maize samples.

140 Means and standard deviations from the UK1990 reference charts wer

141 Fisher Hemorrhage Grade and a lower mean (+/-standard deviation) GCS score (8.66 +/- 4.97 vs 12.09 +/

142 ase parameters (age, mean deviation, pattern standard deviation, glaucoma hemifield test results, FPR

143 A standard-deviation greater individual LC-SES score, with

144 men and 883 women; mean age, 57 years +/- 8 [standard deviation]) had trace or greater visual emphyse

145 ned water (standardized mean difference 0.06 standard deviations higher, 95% CI 0.16 lower to 0.27 hi

146 One-standard-deviation higher PTC2 was associated with 17% (

147 Individual MR analyses showed a 1-standard-deviation-higher HDL cholesterol (OR 0.80; 95%

148 LDL cholesterol (odds ratio [OR] 1.66 per 1-standard-deviation-higher trait; 95% CI: 1.49-1.86; P <

149 The mean visual acuity (+/-standard deviation) improved, with 15.3+/-13.0 letters f

150 oefficient of determination and the residual standard deviation in calibration, validation, and predi

151 breath hold than at free breathing (mean +/- standard deviation in milliliters of gas per milliliters

152 participant night-to-night variation, with a standard deviation in sleep duration of 1.2 +/- 0.7 h.

153 An increase of 1 standard deviation in the CHD genetic risk score was ass

154 ivariate normative comparison (MNC) and -1.5 standard deviations in >=2 neurocognitive domains were s

155 TV was associated with reduced PFS for every standard deviation increase (hazard ratio [HR], 0.193; 9

156 associated with overall cancer risk (OR per standard deviation increase 1.01, 95% CI 0.98-1.05, p=0.

157 r smoking (IVW OR 2.1, 95% CI = 1.1, 3.8 per standard deviation increase in drinks consumed per week)

158 The odds ratio for depression per standard deviation increase in genetically-predicted tri

159 s below these thresholds revealed that a one standard deviation increase in LC omega-3 PUFA (380 mg/d

160 al cancer (IVW OR 2.6, 95% CI = 1.7, 3.9 per standard deviation increase in lifetime smoking behaviou

161 with odds ratios ranging from 1.2 to 1.3 per standard deviation increase in PRS and corresponding lia

162 (beta=0.114, 95% CI=0.035, 0.189), with each standard deviation increase in resilience predicting 12%

163 continuous (HR: 1.08; 95% CI: 1.00-1.17 per standard deviation increase of SoC) variable, and risk o

164 ar disorder (adjusted hazard ratio for a one-standard-deviation increase in PRS=1.11, 95% CI=1.03, 1.

165 ) transformed effect size [median-normalized standard deviation] increase, 95% confidence interval [C

166 obank and GWA consortia, we found that a one standard deviation increment in average acceleration was

167 progression ranged from 1.18 to 1.51 (per 1-standard deviation increment in relative abundance) for

168 Mean +/- standard deviation IOP was 14.0+/-4.2 mmHg in the tube g

169 ral regions, including the frontal (mean +/- standard deviation) (left, 2.16 years +/- 0.29; right, 2

170 The mean (standard deviation) lipid concentrations were LDL choles

171 to VA), were associated with at least a half standard deviation lower RBANS scores at 3- and 12 month

172 etermination higher than 0.9954 and relative standard deviations lower than 5.6%.

173 gnal intensity and reproducibility (relative standard deviation < 10%) across five compounds, which r

174 mal glaucoma hemifield test results, pattern standard deviation <0.05 on 2 examinations, or mean devi

175 and precise (recoveries of 87-115%, relative standard deviation <8.0%).

176 l record (n = 326; mean age, 59 years +/-17 [standard deviation]; male-to-female ratio: 188:138).

177 an square error (0.21 +/- 0.05 [mean SUV +/- standard deviation]), mean peak signal-to-noise ratio (3

178 The mean +/- standard deviation number of mammography screenings unde

179 overies in the range 95-106% with a relative standard deviation of <6.0%.

180 the range of 92.12-110.51% with the relative standard deviation of 1.32-4.32%.

181 signal amplification methods demonstrating a standard deviation of 247 ppb D (a deltaD of 1.6 per mil

182 , respectively, and with an average relative standard deviation of ca. < 10% in the positive ion mode

183 Across all patients, standard deviation of cardiac output in the aAo (0.58 L/

184 The standard deviation of cardiac output observed in the aAo

185 Standard deviation of DCE MRI parameter arterial fractio

186 residual error of the calibration (i.e. the standard deviation of difference between clinical refere

187 -, and apical slices, respectively (mean +/- standard deviation of differences between predicted and

188 he fidelity of inhomogeneous N-QDCs with the standard deviation of energy level distribution sigma(ep

189 ublished epidemiologic study to estimate the standard deviation of hypothetical PM(2.5) concentration

190 The primary end point was standard deviation of lateral position (SDLP; a measure

191 ration for 8.0 mm produced smaller values in standard deviation of mean error (0.45D versus 0.68D), m

192 Measurements with a standard deviation of over 20% and patients who presente

193 en spiked at 1:2:5:10 ratios with an average standard deviation of peptide ratios of 0.34.

194 Summary statistics (mean and standard deviation of regional volumes) are reported for

195 observed clinical effect size was within one standard deviation of the mean predicted effect size for

196 of an integrated displacement sensor with a standard deviation of the position accuracy below lambda

197 The mean +/- standard deviation of the root mean square deviation was

198 muscles with baseline FF below the mean +/- standard deviation of unaffected volunteers (-0.4 cm(2)

199 Their means percentages and standard deviations of accuracy range 100.32 +/- 0.89 to

200 The means and standard deviations of bone marrow blood flow, spatial S

201 s within a given device consistently yielded standard deviations of less than 5% RSD.

202 Standard deviations of logarithms of geometric mean conc

203 iscrimination abilities; children within two standard deviations of the adult group were classified a

204 Means and standard deviations of the SSIM were reported, and stati

205 ear was 1.2 kWh, with a mean energy cost (+/-standard deviation) of $0.22 +/- 0.13.

206 cipation, survivors were an average age (+/- standard deviation) of 16.3 +/- 4.7 years and 32.8 +/- 1

207 Data are shown as either mean +/- [standard deviation] or median [quartile 1-3 range], and

208 O attenuation (OR, 3.2; 95% CI: 1.3, 8.3 per standard deviation, P = .02) were independent predictors

209 pulmonary metastatic lesions by 79% +/- 23 (standard deviation; P < .001).

210 tability and intermediate precision relative standard deviation percentages range 0.395-0.894.

211 ents (102 men; mean age, 57.0 years +/- 9.7 [standard deviation]) presenting to the ED with ACP.

212 quantitative VF mean deviation (MD), pattern standard deviation (PSD), and mean VF sectoral pattern d

213 eld parameters (mean deviation (MD), pattern standard deviation (PSD), and visual field index (VFI)).

214 s determined by mean deviation (MD), pattern standard deviation (PSD), and visual field index (VFI).

215 tion error (median and mean absolute errors; standard deviation; range of errors; percentage of eyes

216 of 255 patients (mean age, 26 years +/- 23 [standard deviation]; range, 0-88 years; 157 male patient

217 healthy pediatric patients (14 years +/- 3 [standard deviation]; range, 9-18 years; 27 of 48 [56%] m

218 he range of 91.1% to 102.1%, with a relative standard deviation ranging from 0.08 to 9.29%.

219 ined as the ratio of average mobility to the standard deviation), respectively.

220 rease in ROP stage from 0 to 2, the mean +/- standard deviation retinal thickness at the fovea increa

221 ,000 plates/m for galactose and the relative standard deviation (RSD) for ten consecutive analyses of

222 e of the method was demonstrated by relative standard deviation (RSD) lower than 0.83% for the (1)D a

223 m 6-1600 kDa, exhibiting an average relative standard deviation (RSD) of 0.43 +/- 0.20%.

224 ntification (LLOQ) of 1.0 nM with a relative standard deviation (RSD, n = 3) of 0.85%.

225 repeatable results were achieved (%relative standard deviations (RSD's) 5-16%).

226 The relative standard deviations (RSD) between the cycles for human p

227 beta: 0.22 E%; 95% CI: 0.06, 0.38 E% per BMI standard deviation score).

228 vided by the square of the height in meters) standard-deviation score at week 56.

229 UK1990 reference charts were used to compute standard deviation scores (SDS) for our cohort.

230 ear of age), small height at diagnosis (<= 2 standard deviation scores; RR, 6.74 [95% CI, 4.61 to 9.8

231 onmental conditions, and lower (worse) mean (standard deviation) scores on the modified Rasch-scored

232 s revealed that 19.8% of long eyes had LD >1 standard deviation (SD) above and that 5.2% had LD <1 SD

233 VP-I [n = 108]; placebo [n = 321]); mean and standard deviation (SD) age was 44.3 (22.9) years, and m

234 ta-analysis of observational studies, each 1-standard deviation (SD) higher level of 25(OH)D was asso

235 d aerosol samples, we collected the mean and standard deviation (SD) if these values were reported, d

236 een eyes of 409 patients with a mean age +/- standard deviation (SD) of 70.2 +/- 9.8 years and follow

237 is important for breeding, we calculated the standard deviation (SD) of individual root measurements

238 The mean age +/- standard deviation (SD) of the patients was 28.4 +/- 5.6

239 Among those canceled, the mean age +/- standard deviation (SD) of the patients was 70.3 +/- 14.

240 cted and observed values, and each patient's standard deviation (SD) of the residuals was used as a m

241 WH scored on average 0.06 (95% CI 0.01-0.12) standard deviation (SD) units higher on the conventional

242 Maternal and paternal BMI (standard deviation (SD) units) had a strong association

243 Participants aged 46.8 (standard deviation (SD), 0.7) years (n = 5,346) from the

244 age at symptom onset was 0.8 +/- 0.6 years [standard deviation (SD), range 0.2-5.0], the mean age at

245 zed, 95 (54%) were adherent (51% male; mean [standard deviation (SD)] age: 56.1 [59.8] months), 5 (3%

246 first-level administrative units = 0.277 and standard deviation [SD] 0.114) to 0.755 in Albania (with

247 age for cases and controls were 49.6 years (standard deviation [SD] 8.7 years) and 48.9 years (SD 8.

248 RNFL, and GC-IPL thickness were 1.31 mm(2) (standard deviation [SD] = 0.22), 93.7 mum (SD = 9.3) and

249 Baseline VAs (Mean+/-standard deviation [SD] Early Treatment Diabetic Retinop

250 95% CI: 0.58 to 0.95, respectively, for a 1-standard deviation [SD] increase).

251 ifty-eight (79.5%) were female, with a mean (standard deviation [SD]) age at presentation of 35.2 (14

252 self-efficacy from an average score of 2.6 (standard deviation [SD], 0.3) to 2.8 (SD, 0.2) on the ED

253 ndred fifteen HIV+ adolescents, mean age 12 (standard deviation [SD], 1.6) years, 50.4% male, and 110

254 neurocognitive outcomes (expected mean, 50; standard deviation [SD], 10).

255 Mean age of PLWH was 50.7 (standard deviation [SD], 11.1) years and 97.4% received

256 Mean BCVA was 14.9 letters (standard deviation [SD], 12.3 letters; Snellen equivalen

257 alukhali Expansion Site (mean age, 21 years; standard deviation [SD], 18 years; 52% female).

258 injections over 12 months were similar: 5.6 (standard deviation [SD], 2.9) versus 4.9 (SD, 3.2; P = 0

259 perative IOP for all patients was 15.2 mmHg (standard deviation [SD], 3.4 mmHg), which decreased to 1

260 Survivors (mean age +/- standard deviation [SD], 35.6 +/- 8.8 years) had lower m

261 Forty-six patients (mean age, 69.9 years; standard deviation [SD], 4.6 years; range, 20-88 years;

262 isk score at entry into the cohort was 6.8% (standard deviation [SD], 7.1%) and FRS was 13.1% (SD, 10

263 from 310 eyes of 182 patients (mean age +/- standard deviation [SD], 78.8 +/- 8.8 years) with nonexu

264 ean age 19.8 months (range, 0.9-33.4 months; standard deviation [SD], 9.4 months) at the first handhe

265 utcome (5-year event-free survival [EFS] +/- standard deviation [SD], 95% +/- 2%; 5-year overall surv

266 d 884 STAY) for a mean of 2.0 years (+/- 0.1 standard deviation [SD]; mean age 48.8 years, SD +/- 8.8

267 of 145 patients (mean age, 61 years +/- 14 [standard deviation {SD}]; 68 female patients and 77 male

268 r fractional anisotropy was lower in [0.423 (standard deviation, SD 0.023) versus 0.446 (SD 0.016), P

269 m polyamide microplastics demonstrated 101% (standard deviation, SD 27%) and 113% (SD 15%) recovery f

270 adherence over 3 months was 74% +/- 21% (+/-standard deviation, SD).

271 4 had received DEX implant previously; mean (standard deviation; SD) duration between prior and study

272 at baseline and 3, 6, 9, and 12 months, and standard deviations (SDs) across 12 months were calculat

273 10 participants (mean age, 66 years +/- 10 [standard deviation]; six men) referred for a PET/CT onco

274 nd six women; mean age, 56.8 years +/- 11.8 [standard deviation]) suspected of having thoracic aortic

275 The mean +/- standard deviation time between implantation and ASN dia

276 -mutated gliomas (mean age, 50 years +/- 21 [standard deviation]; two men) and three healthy particip

277 values ranged from 84 to 120% with relative standard deviation values lower than 11%.

278 Relative standard deviation values obtained were all below 20% an

279 The mean (standard deviation) values for apolipoproteins B and A-I

280 est (mean rest vs stress, 38.7 msec +/- 2.5 [standard deviation] vs 45.4 msec +/- 3.3, respectively;

281 the 904 participants, baseline mean age +/- standard deviation was 14.0 +/- 1.5 years, hemoglobin A1

282 gnificant change in ambulatory SBP (mean +/- standard deviation) was -0.6 +/- 6.2 mm Hg in the placeb

283 Mean effective dose (+/- standard deviation) was 0.16 +/- 0.04 mSv for the 32-MDC

284 UK Biobank: the estimated hazard ratios per standard deviation were 1.10 (95% confidence interval: 1

285 he validation studies, recovery and relative standard deviation were obtained in range of 92.5-104.3%

286 Mean and standard deviation were recorded and differences in atte

287 s were within the range of 65-141%, relative standard deviations were <20% at all three spiking level

288 Relative standard deviations were below 9%, and recoveries close

289 mediate precision, was established (relative standard deviations were lower than or equal to 10%).

290 1 women) with a mean age of 69 years +/- 14 (standard deviation) were enrolled prospectively in the P

291 with glioma (mean age, 51.3 years +/- 14.3 [standard deviation]) were compared with those in 10 heal

292 red eleven women (mean age, 52 years +/- 13 [standard deviation]) were evaluated with a total of 111

293 ns from 28 women (mean age, 50 years +/- 13 [standard deviation]) were evaluated.

294 of 418 041 women (mean age, 54 years +/- 10 [standard deviation]) were included, and 1 186 045 digita

295 For example, the relative standard deviation, which is the evaluation criterion of

296 patients (21 men; mean age, 61 years +/- 10 [standard deviation]) who underwent 4D flow MRI from 2006

297 wenty-four women (mean age, 55 years +/- 11 [standard deviation]) with HER2-negative primary breast c

298 ecutive patients (mean age, 66 years +/- 10 [standard deviation]) with metastases to 23 patients (mea

299 The mean age was 58.5 years +/- 15.6 [standard deviation], with a male predominance (65.8% vs

300 d retinal imaging during 4.6+/-1.9 (mean +/- standard deviation) years.